NCT00670449 - An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis | Biotech Hunter

Enrollment

143

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Multiple Sclerosis

Interventions

DRUG

Fingolimod

Fingolimod was supplied in capsules.

Trial Locations (20)

276-8524

Novartis Investigative Site, Chiba

791-0295

Novartis Investigative Site, Ehime

807-8555

Novartis Investigative Site, Fukuoka

371-8511

Novartis Investigative Site, Gunma

650-0017

Novartis Investigative Site, Hyōgo

305-8576

Novartis Investigative Site, Ibaraki

259-1193

Novartis Investigative Site, Kanagawa

604-8453

Novartis Investigative Site, Kyoto

616-8255

Novartis Investigative Site, Kyoto

020-8505

Novartis Investigative Site, Morioka

951-8520

Novartis Investigative Site, Niigata

556-0016

Novartis Investigative Site, Osaka

589-8511

Novartis Investigative Site, Osaka

Unknown

Novartis Investigative Site, Osaka

060-8648

Novartis Investigative Site, Sapporo

329-0498

Novartis Investigative Site, Tochigi

113-8519

Novartis Investigative Site, Tokyo

145-0065

Novartis Investigative Site, Tokyo

162-8666

Novartis Investigative Site, Tokyo

641-8510

Novartis Investigative Site, Wakayama